Regeneron Reports Third Quarter 2026 Financial and Operating Results
Revenue$5.1 billion+36% YoY
EPS$18.45
Outlookissuedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.